Ex Parte STEWART et al - Page 3



                 Appeal No. 2003-1417                                                         Page 3                   
                 Application No. 09/298,404                                                                            

                 different pathways can be modulated by the presence or absence of signals                             
                 generated by other receptors. . . .  Adaptor molecules may be critical in                             
                 integrating multiple signaling cascades and in determining the cell type specific                     
                 response to extracellular stimuli.”  Specification, page 1.                                           
                        The specification discloses the cloning and characterization of three                          
                 human cDNAs encoding putative adaptor proteins designated Nsp1, Nsp2, and                             
                 Nsp3.  The amino acid sequences of the Nsp1, Nsp2, and Nsp3 proteins are                              
                 shown in the specification’s SEQ ID NOs 1, 3, and 5, respectively.  The                               
                 specification discloses that “[s]everal characteristics suggest that Nsp1 could                       
                 play an important role in modulating the response to external stimuli.”  Page 30.                     
                 One such characteristic is that epidermal growth factor (EGF) “induced a rapid                        
                 tyrosine phosphorylation of Nsp1 (SEQ ID NO:1).”  Page 60.                                            
                        Among the related products disclosed in the specification are antibodies                       
                 that bind to the Nsp1, Nsp2, or Nsp3 proteins.  See, e.g., pages 4-5 and 41-49.                       
                 Such antibodies are disclosed to be “promising drug candidates” for inhibiting the                    
                 production or activity of Nsp1, Nsp2, or Nsp3.  See page 41.                                          
                                                     Discussion                                                        
                        Claims 60, 61, and 62 are directed to “[a]n antibody which specifically                        
                 binds to” Nsp1, Nsp2, or Nsp3, respectively.  The remaining claims depend on                          
                 one or more of claims 60, 61, or 62.                                                                  










Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007